Clinical trials
Recruiting Hypertension trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
67 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 8 |
| 2023 | 4 |
| 2024 | 10 |
| 2025 | 21 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 67 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| China National Center for Cardiovascular Diseases | 5 |
| Beijing Anzhen Hospital | 3 |
| Beijing Friendship Hospital | 3 |
| Peking University | 3 |
| Shanghai Jiao Tong University School of Medicine | 3 |
| Third Military Medical University | 3 |
| Qifu Li | 2 |
| Ruijin Hospital | 2 |
| Shenzhen Ausa Pharmed Co.,Ltd | 2 |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 67 |
| Cardiovascular Diseases | 13 |
| Diabetes Mellitus | 11 |
| Dyslipidemias | 6 |
| Obesity | 6 |
| Renal Insufficiency, Chronic | 6 |
| Hyperaldosteronism | 5 |
| Atrial Fibrillation | 4 |
| Essential Hypertension | 4 |
| Hyperlipidemias | 4 |
Trials
Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.